How Boston Analytical Streamlines Method Development and Validation
In the pharmaceutical industry, method development and validation challenges have long had scientists simultaneously working toward streamlining analytical testing methods while upholding GMP quality and meeting method specifications.
The challenge is to expeditiously develop an analytical method that will meet the end user’s need while keeping unforeseen problems from arising during method validation, which is certainly not a new predicament in pharmaceutical laboratories.
It’s a balancing act — one that scientists have been familiar with for decades.
To continue reading, please fill out the form.